Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
People living with both viruses remain at risk for hepatocellular carcinoma despite antiviral therapy.
Among HIV-positive people, it is preferable to treat hepatitis B with a two-drug regimen rather than with monotherapy.
Epivir (lamivudine) and Viread (tenofovir) are likely safe for women to use while breast-feeding.
The looming threat of a government shutdown on October 1 may spell potential delays in FDA approvals of new drugs.
The HIV antiretroviral Viread (tenofovir) is highly effective in combating both HIV and hepatitis B among those coinfected with both viruses
Viread (tenofovir) and Epivir (lamivudine) lower the risk of infection with hepatitis B among HIV-positive gay men who havenâ€™t been vac...
Tenofovir is safe and effective for long-term treatment of hepatitis B, and leads to few kidney-related side effects and no clinically relevan...
About 12 percent of HIV-positive people with chronic hepatitis B virus (HBV) infection failed to control their HBV after one year with Viread...
Gilead Sciences announced earlier this week that the U.S. Food and Drug Administration has approved Viread for the treatment of chronic hepa...
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.